Allosteric drugs acting at muscarinic acetylcholine receptors

Neurochemical Research

Volumn 28, Issue 3-4, 2003, Pages 419-422

  Waelbroeck, Magali ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Alcuronium; Allosteric drugs; Facilitator effects; Gallamine; Muscarinic receptors; Subtype selectivity

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; DEXTRAN; GALLAMINE; GANGLION BLOCKING AGENT; GO 7874; HEPARIN; KT 5720; KT 5823; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; NEUROMUSCULAR BLOCKING AGENT; TACRINE; TRYPAN BLUE; UNCLASSIFIED DRUG;

ALLOSTERISM; ARTICLE; BINDING SITE; DRUG BINDING SITE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING;

ALLOSTERIC REGULATION; ANIMALS; LIGANDS; MODELS, BIOLOGICAL; RECEPTORS, MUSCARINIC;

EID: 0037375881     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022888332221     Document Type: Article

References (48)

1. Bonner, T. I. 1989. New subtypes of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 10 Suppl:11-15.
2. Tuček, S., Jakubík, J., Doležal, V., and El Fakahany, E. E. 1998. Positive effects of allosteric modulators on the binding properties and the function of muscarinic acetylcholine receptors. J. Physiol. (Paris) 92:241-243.
3. Poyner, D. R., Birdsall, N. J., Curtis, C., Eveleigh, P., Hulme, E. C., Pedder, E. K., and Wheatley, M. 1989. Binding and hydrodynamic properties of muscarinic receptor subtypes solubilized in 3-(3-cholamidopropyl)dimethylammonio-2-hydroxyl-propanesulfonate. Mol. Pharmacol. 36:420-429.
4. Musílková, J. and Tuček, S. 1995. Positive allosteric action of alcuronium on solubilized cardiac muscarinic receptors. Neurochem. Int. 27:337-343.
5. Berrie, C. P., Birdsall, N.J., Hulme, E. C., Keen, M., and Stockton, J. M. 1984. Solubilization and characterization of guanine nucleotide-sensitive muscarinic agonist binding sites from rat myocardium. Br. J. Pharmacol. 82:853-861.
6. Gurevich, V. V., Pals-Rylaarsdam, R., Benovic, J. L., Hosey, M. M., and Onorato, J. J. 1997. Agonist-receptor-arrestin: An alternative ternary complex with high agonist affinity. J. Biol. Chem. 272:28849-28852.
7. Ellis, J., Huyler, J., and Brann, M. R. 1991. Allosteric regulation of cloned M1-M5 muscarinic receptor subtypes. Biochem. Pharmacol. 42:1927-1932.
8. Melchiorre, C., Minarini, A., Angeli, P., Giardina, D., Gulini, U., and Quaglia, W. 1989. Polymethylene tetraamines as muscarinic receptor probes. Trends Pharmacol. Sci. 10 Suppl:55-59.
9. Jakubík, J., Bačáková, L., El Fakahany, E. E., and Tuček, S. 1995. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 274:1077-1083.
10. Liang, J. S., Carsi-Gabrenas, J., Krajewski, J. L., McCafferty, J. M., Purkerson, S. L., Santiago, M. P., Strauss, W. L., Valentine, H. H., and Potter, L. T. 1996. Anti-muscarinic toxins from dendroaspis angusticeps. Toxicon 34:1257-1267.
11. Gnagey, A. L., Seidenberg, M., and Ellis, J. 1999. Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors. Mol. Pharmacol. 56:1245-1253.
12. Mohler, H., Fritschy, J. M., and Rudolph, U. 2002. A new benzodiazepine pharmacology. J. Pharmacol. Exp. Ther. 300:2-8.
13. Jakubík, J., Bačáková, L., El Fakahany, E. E., and Tuček, S. 1997. Positive cooperativity of acetylcholine and other agonists with allosteric ligands on muscarinic acetylcholine receptors. Mol. Pharmacol. 52:172-179.
14. Lazareno, S., Gharagozloo, P., Kuonen, D., Popham, A., and Birdsall, N. J. 1998. Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: Radioligand binding studies. Mol. Pharmacol. 53:573-589.
15. Doležal, V. and Tuček, S. 1998. The effects of brucine and alcuronium on the inhibition of [3H] acetylcholine release from rat striatum by muscarinic receptor agonists. Br. J. Pharmacol. 124:1213-1218.
16. Ehlert, F. J. 1988. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol. Pharmacol. 33:187-194.
17. Tränkle, C., Weyand, O., Schröter, A., and Mohr, K. 1999. Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors. Mol. Pharmacol. 56:962-965.
18. Stockton, J. M., Birdsall, N. J., Burgen, A. S., and Hulme, E. C. 1983. Modification of the binding properties of muscarinic receptors by gallamine. Mol. Pharmacol. 23:551-557.
19. Mitchelson, F. 1975. Antimuscarinic action of an alkane-bisammonium compound alone and in combination with (+)benzetimide. Eur. J. Pharmacol. 33:237-246.
20. Proška, J. and Tuček, S. 1994. Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors. Mol. Pharmacol. 45:709-717.
21. Motulsky, H. J. and Mahan, L. C. 1984. The kinetics of competitive radioligand binding predicted by the law of mass action. Mol. Pharmacol. 25:1-9.
22. Waelbroeck, M. 1994. Identification of drugs competing with D-tubocurarine for an allosteric site on cardiac muscarinic receptors. Mol. Pharmacol. 46:685-692.
23. Tuček, S. and Progka, J. 1995. Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol. Sci. 16:205-212.
24. Lazareno, S. and Birdsall, N. 1996. Quantitation of allosteric interactions. Trends Pharmacol. Sci. 17: 443-444.
25. Jakubík, J., Bačáková, L., Lisá, V., El Fakahany, E. E., and Tuček, S. 1996. Activation of muscarinic acetylcholine receptors via their allosteric binding sites. Proc. Natl. Acad. Sci. USA 93:8705-8709.
26. Jakubík, J., Haga, T., and Tuček, S. 1998. Effects of an agonist, allosteric modulator, and antagonist on guanosine-gamma[35S]thiotriphosphate binding to liposomes with varying muscarinic receptor/Go protein stoichiometry. Mol. Pharmacol. 54:899-906.
27. Maaß, A. and Mohr, K. 1996. Opposite effects of alcuronium on agonist and on antagonist binding to muscarinic receptors. Eur. J. Pharmacol. 305:231-234.
28. Hejnovà, L., Tuček, S., and El Fakahany, E. E. 1995. Positive and negative allosteric interactions on muscarinic receptors. Eur. J. Pharmacol. 291:427-430.
29. Lysiková, M., Havlas, Z., and Tuček, S. 2001. Interactions between allosteric modulators and 4-DAMP and other antagonists at muscarinic receptors: Potential significance of the distance between the N and carboxyl C atoms in the molecules of antagonists. Neurochem. Res. 26:383-394.
30. Zlotos, D. P., Buller, S., Tränkle, C., and Mohr, K. 2000. Bisquaternary caracurine V derivatives as allosteric modulators of ligand binding to M2 acetylcholine receptors. Bioorg. Med. Chem. Lett. 10:2529-2532.
31. Gerstin, E. H., Jr., Luong, T., and Ehlert, F. J. 1992. Heparin, dextran and trypan blue allosterically modulate M2 muscarinic receptor binding properties and interfere with receptor-mediated inhibition of adenylate cyclase. J. Pharmacol. Exp. Ther. 263:910-917.
32. Wang, S. Z., Edmundson, R., Zhu, S. Z., and El Fakahany, E. E. 1996. Selective enhancement of antagonist ligand binding at muscarinic M2 receptors by heparin due to receptor uncoupling. Eur. J. Pharmacol. 296:113-118.
33. Lee, N. H., Hu, J., and El Fakahany, E. E. 1992. Modulation by certain conserved aspartate residues of the allosteric interaction of gallamine at the M1 muscarinic receptor. J. Pharmacol. Exp. Ther. 262:312-316.
34. Ellis, J. and Seidenberg, M. 2000. Site-directed mutagenesis implicates a threonine residue in TM6 in the subtype selectivities of UH-AH 37 and pirenzepine at muscarinic receptors. Pharmacology 61:62-69.
35. Ellis, J. and Seidenberg, M. 2000. Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: Studies with chimeric receptors. Mol. Pharmacol. 58:1451-1460.
36. Krejči, A. and Tuček, S. 2001. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors. Mol. Pharmacol. 60:761-767.
37. Buller, S., Zlotos, D. P., Mohr, K., and Ellis, J. 2002. Allosteric site on muscarinic acetylcholine receptors: A single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands. Mol. Pharmacol. 61:160-168.
38. Birdsall, N. J., Lazareno, S., Popham, A., and Saldanha, J. 2001. Multiple allosteric sites on muscarinic receptors. Life Sci. 68:2517-2524.
39. Birdsall, N. J., Burgen, A. S., Hulme, E. C., Stockton, J. M., and Zigmond, M. J. 1983. The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart. Br. J. Pharmacol. 78:257-259.
40. Brunner, F., Waelbroeck, M., and Christophe, J. 1986. Secoverine is a non-selective muscarinic antagonist on rat heart and brain receptors. Eur. J. Pharmacol. 127:17-25.
41. Lee, N. H. and El Fakahany, E. E. 1990. The allosteric binding profile of himbacine: A comparison with other cardioselective muscarinic antagonists. Eur. J. Pharmacol. 179:225-229.
42. Waelbroeck, M., Camus, J., Tastenoy, M., and Christophe, J. 1992. Binding properties of nine 4-diphenyl-acetoxy-Nmethyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes. Br. J. Pharmacol. 105:97-102.
43. Ellis, J. and Seidenberg, M. 1999. Competitive and allosteric interactions of 6-chloro-5,10-dihydro-5-[(1-methyl-4-piperidinyl) acetyl]-11H-dibenzo[b,e][1,4]diazepine-11-one hydrochloride (UH-AH 37) at muscarinic receptors, via distinct epitopes. Biochem. Pharmacol. 57:181-186.
44. Lanzafame, A., Christopoulos, A., and Mitchelson, F. 2001. The allosteric interaction of otenzepad (AF-DX 116) at muscarinic M2 receptors in guinea pig atria. Eur. J. Pharmacol. 416:235-244.
45. Jakubík, J., El Fakahany, E. E., and Tuček, S. 2000. Evidence for a tandem two-site model of ligand binding to muscarinic acetylcholine receptors. J. Biol. Chem. 275:18836-18844.
46. Potter, L. T., Ferrendelli, C. A., Hanchett, H. E., Hollifield, M. A., and Lorenzi, M. V. 1989. Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors. Mol. Pharmacol. 35:652-660.
47. Lazareno, S., Popham, A., and Birdsall, N. J. 2000. Allosteric interactions of staurosporine and other indolocarbazoles with N[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: Identification of a second allosteric site. Mol. Pharmacol. 58:194-207.
48. Ellis, J. and Seidenberg, M. 1989. Gallamine exerts biphasic allosteric effects at muscarinic receptors. Mol. Pharmacol. 35:173-176.